Sandoz Group (OTCMKTS:SDZNY) Sees Unusually-High Trading Volume – Still a Buy?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) saw strong trading volume on Thursday . 63,058 shares changed hands during mid-day trading, an increase of 140% from the previous session’s volume of 26,298 shares.The stock last traded at $78.62 and had previously closed at $78.70.

Analyst Ratings Changes

Separately, Barclays raised Sandoz Group to a “strong-buy” rating in a research report on Monday, October 13th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy”.

Sandoz Group Stock Performance

The company has a debt-to-equity ratio of 0.62, a current ratio of 1.29 and a quick ratio of 0.82. The company has a 50 day simple moving average of $75.29 and a 200-day simple moving average of $66.65.

Sandoz Group Company Profile

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.